Health care stocks were mixed Wednesday afternoon with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%.
The iShares Biotechnology ETF (IBB) rose 1.2%.
In corporate news, CVS Health (CVS) shares jumped past 12% as a Q3 revenue beat overshadowed an earnings miss.
AstraZeneca (AZN) four senior executives in China, including two former employees, are being investigated for alleged violations of Chinese laws on drug importation and data privacy, Bloomberg reported, citing the company. AstraZeneca shares were falling 3.2%.
Novo Nordisk (NVO) reported Q3 earnings Wednesday of 6.12 Danish kroner ($0.88) per diluted American depositary share, up from 5 kroner a year earlier and above the expectation of three analysts polled by Capital IQ calling for 5.95 kroner. Q3 net sales were 71.31 billion kroner, up from 58.73 billion kroner in the year-ago period but below the Capital IQ consensus analyst estimate of 71.87 billion kroner. Novo shares shed 3.7%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。